AbbVie Statistics
Total Valuation
AbbVie has a market cap or net worth of $360.10 billion. The enterprise value is $417.93 billion.
Important Dates
The last earnings date was Wednesday, October 30, 2024, before market open.
| Earnings Date | Oct 30, 2024 |
| Ex-Dividend Date | Jan 15, 2025 |
Share Statistics
AbbVie has 1.77 billion shares outstanding. The number of shares has decreased by -0.08% in one year.
| Shares Outstanding | 1.77B |
| Shares Change (YoY) | -0.08% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 0.08% |
| Owned by Institutions (%) | 73.07% |
| Float | 1.76B |
Valuation Ratios
The trailing PE ratio is 71.04 and the forward PE ratio is 17.10. AbbVie's PEG ratio is 2.07.
| PE Ratio | 71.04 |
| Forward PE | 17.10 |
| PS Ratio | 6.49 |
| Forward PS | 6.24 |
| PB Ratio | 53.12 |
| P/FCF Ratio | n/a |
| PEG Ratio | 2.07 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 82.29 |
| EV / Sales | 7.53 |
| EV / EBITDA | 15.39 |
| EV / EBIT | 22.36 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 10.40 |
| Debt / EBITDA | 2.58 |
| Debt / FCF | n/a |
| Interest Coverage | 7.65 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | 15.46% |
| Revenue Per Employee | $1.11M |
| Profits Per Employee | $101,580 |
| Employee Count | 50,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AbbVie has paid $2.06 billion in taxes.
| Income Tax | 2.06B |
| Effective Tax Rate | 28.68% |
Stock Price Statistics
The stock price has increased by +43.68% in the last 52 weeks. The beta is 0.62, so AbbVie's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | +43.68% |
| 50-Day Moving Average | 193.99 |
| 200-Day Moving Average | 177.73 |
| Relative Strength Index (RSI) | 69.55 |
| Average Volume (20 Days) | 5,262,437 |
Short Selling Information
The latest short interest is 16.18 million, so 0.92% of the outstanding shares have been sold short.
| Short Interest | 16.18M |
| Short Previous Month | 17.79M |
| Short % of Shares Out | 0.92% |
| Short % of Float | 0.92% |
| Short Ratio (days to cover) | 3.56 |
Income Statement
In the last 12 months, AbbVie had revenue of $55.53 billion and earned $5.08 billion in profits. Earnings per share was $2.87.
| Revenue | 55.53B |
| Gross Profit | 38.95B |
| Operating Income | 18.69B |
| Pretax Income | 7.06B |
| Net Income | 5.08B |
| EBITDA | 27.16B |
| EBIT | 18.69B |
| Earnings Per Share (EPS) | $2.87 |
Full Income StatementBalance Sheet
The company has $13.16 billion in cash and $70.94 billion in debt, giving a net cash position of -$57.78 billion or -$32.71 per share.
| Cash & Cash Equivalents | 13.16B |
| Total Debt | 70.94B |
| Net Cash | -57.78B |
| Net Cash Per Share | -$32.71 |
| Equity (Book Value) | 6.82B |
| Book Value Per Share | 3.84 |
| Working Capital | n/a |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 70.14%, with operating and profit margins of 33.65% and 9.22%.
| Gross Margin | 70.14% |
| Operating Margin | 33.65% |
| Pretax Margin | 12.96% |
| Profit Margin | 9.22% |
| EBITDA Margin | 48.90% |
| EBIT Margin | 33.65% |
| FCF Margin | 32.33% |